Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
212.3 USD | +1.38% | +1.79% | -15.61% |
May. 08 | Morgan Stanley Cuts Price Target on Penumbra to $235 From $240, Keeps Equalweight Rating | MT |
May. 07 | Penumbra Q1 Non-GAAP EPS, Revenue Increase; Reaffirms 2024 Revenue Outlook | MT |
Chart calendar Penumbra, Inc.
Upcoming events on Penumbra, Inc.
Past events on Penumbra, Inc.
2024-05-07 04:30 pm | Q1 2024 Earnings Call |
2024-05-07 04:05 pm | Q1 2024 Earnings Release |
2024-02-22 04:30 pm | Q4 2023 Earnings Call |
2024-02-22 04:05 pm | Q4 2023 Earnings Release |
2024-01-08 11:15 am | JPMorgan Healthcare Conference |
2023-11-28 01:30 pm | Piper Sandler Healthcare Conference |
2023-11-02 04:30 pm | Q3 2023 Earnings Call |
2023-11-02 04:05 pm | Q3 2023 Earnings Release |
2023-09-12 02:00 pm | Baird Global Healthcare Conference |
2023-09-12 02:00 pm | Baird Global Healthcare Conference |
2023-09-06 08:00 am | Wells Fargo Healthcare Conference |
2023-08-09 09:00 am | Canaccord Genuity Growth Conference |
2023-08-01 04:30 pm | Q2 2023 Earnings Call |
2023-08-01 04:05 pm | Q2 2023 Earnings Release |
2023-06-07 10:20 am | William Blair Growth Stock Conference |
2023-05-31 02:00 pm | Annual General Meeting |
2023-05-16 11:30 am | RBC Global Healthcare Conference |
2023-05-09 01:40 pm | Bank of America Healthcare Conference |
2023-05-02 04:30 pm | Q1 2023 Earnings Call |
2023-05-02 12:05 pm | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 547 544 0.7% | 560 550 1.96% | 748 738 1.3% | 847 845 0.26% | 1 059 1 061 -0.2% | 1 242 |
EBITDA Million USD | Released Forecast Spread | 55,6 53,5 4.04% | 15,5 7,85 97.24% | 51,5 62,4 -17.49% | 38,7 37,7 2.71% | 129 122 5.47% | 174 |
EBIT Million USD | Released Forecast Spread | 47,5 46,3 2.55% | 2,60 -23,3 111.13% | 35,0 41,7 -16.05% | 14,4 14,1 2.5% | 101 98,2 3.12% | 140 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 50,1 49,0 2.32% | 0,00 0,00 - | -10,5 11,4 -192.53% | 3,89 5,86 -33.62% | 79,7 84,6 -5.87% | 138 |
Net income Million USD | Released Forecast Spread | 48,5 38,9 24.57% | -15,7 -23,1 32.03% | 5,28 16,3 -67.58% | -2,00 5,12 -139.11% | 91,0 71,8 26.61% | 107 |
EPS USD | Released Forecast Spread | 1,34 1,08 24.07% | -0,44 -0,63 30.16% | 0,14 0,44 -67.82% | -0,05 0,13 -137.74% | 2,32 1,85 25.45% | 2,75 |
Announcement Date | 25/02/20 | 23/02/21 | 22/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 204 195 4.35% | 208 206 1.02% | 214 212 0.64% | 221 217 1.93% | 241 230 5.09% | 261 253 3.26% | 271 265 2.19% | 285 287 -0.65% | 279 275 1.51% | 295 | 317 | 339 | 325 | 347 |
EBITDA Million USD | Released Forecast Spread | 3,47 7,89 -56.11% | 5,79 4,67 23.89% | 14,0 6,43 118.3% | 13,7 14,1 -2.87% | 17,0 14,1 20.17% | 27,0 22,6 19.36% | 40,2 30,2 33.03% | 44,4 41,6 6.89% | 26,8 25,7 4.19% | 37,0 | 53,4 | 59,3 | 40,9 | 47,1 |
EBIT Million USD | Released Forecast Spread | -2,26 1,61 -240.13% | 1,65 -0,78 311.71% | 7,81 1,54 407.47% | 7,21 8,43 -14.45% | 10,4 5,93 75.14% | 20,3 13,6 49.11% | 33,2 21,8 52.4% | 37,4 35,1 6.73% | 19,3 17,0 13.79% | 26,8 | 42,6 | 49,5 | 35,0 | 41,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,10 2,05 -348.75% | -1,17 0,58 -301.35% | 3,04 1,59 91.46% | 7,13 7,98 -10.7% | 8,65 5,50 57.19% | 19,5 13,5 44.74% | 13,3 20,5 -35.2% | 38,2 33,6 13.52% | 14,6 18,1 -19.33% | 26,8 | 43,0 | 50,8 | 35,8 | 42,0 |
Net income Million USD | Released Forecast Spread | 0,08 1,59 -95.04% | -3,69 0,44 -941.2% | -2,27 1,20 -288.72% | 3,88 6,16 -37.07% | 8,56 4,36 96.59% | 19,0 10,9 74.41% | 9,21 16,2 -42.95% | 54,2 27,4 97.86% | 11,0 12,3 -10.27% | 21,0 | 33,6 | 39,8 | 29,4 | 34,6 |
EPS USD | Released Forecast Spread | 0,00 0,04 - | -0,10 0,01 -887.4% | -0,06 -0,24 74.52% | 0,10 0,16 -37.62% | 0,22 0,11 96.69% | 0,48 0,28 72.57% | 0,23 0,43 -45.9% | 1,38 0,71 93.64% | 0,28 0,31 -9.98% | 0,54 | 0,86 | 1,02 | 0,74 | 0,87 |
Announcement Date | 03/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 02/05/23 | 01/08/23 | 02/11/23 | 22/02/24 | 07/05/24 | - | - | - | - | - |
2024-05-14 | ASAHI INTECC CO., LTD.: Q3 2024 Earnings Release |
2024-05-15 02:00 am | IMPLANTICA AG: Q1 2024 Earnings Release |
2024-07-18 02:00 am | GETINGE AB: Q2 2024 Earnings Release |
2024-07-23 | CVRX, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | NOVOCURE LIMITED: Q2 2024 Earnings Release (Projected) |
2024-07-30 | INARI MEDICAL, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-31 | IRADIMED CORPORATION: Q2 2024 Earnings Release (Projected) |
2024-08-04 | WON TECH CO.,LTD.: Q2 2024 Earnings Release (Projected) |
2024-08-04 | SI-BONE, INC.: Q2 2024 Earnings Release (Projected) |
2024-08-04 | PENUMBRA, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Penumbra, Inc.
2024-05-08 | WON TECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
2024-05-08 12:20 pm | CHEMOMETEC A/S: Q3 2024 Sales and Revenue Release - Trading Statement |
2024-05-07 04:05 pm | MASIMO CORPORATION: Q1 2024 Earnings Release |
2024-05-07 04:05 pm | TREACE MEDICAL CONCEPTS, INC.: Q1 2024 Earnings Release |
2024-05-07 04:05 pm | PENUMBRA, INC.: Q1 2024 Earnings Release |
2024-05-06 04:09 pm | SI-BONE, INC.: Q1 2024 Earnings Release |
2024-05-06 04:05 pm | SHOCKWAVE MEDICAL, INC.: Q1 2024 Earnings Release |
2024-05-02 08:30 am | IRADIMED CORPORATION: Q1 2024 Earnings Release |
2024-05-02 07:00 am | NOVOCURE LIMITED: Q1 2024 Earnings Release |
2024-04-30 04:05 pm | INARI MEDICAL, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PEN Stock
- Calendar Penumbra, Inc.